“Lapatinib, trastuzumab or the combination added to neoadjuvant chemotherapy for breast cancer”, Bangladesh J Pharmacol, vol. 11, no. 4, pp. 863–868, Oct. 2016, doi: 10.3329/bjp.v11i4.27384.